Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 22, 2023 16:30 ET | Source: Cellectis Inc.

Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023

NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving...
December 22, 2023 16:30 ET | Source: Cellectis Inc.

Résultats de l’Assemblée Générale Mixte de Cellectis du 22 décembre 2023

NEW YORK, 22 déc. 2023 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d’édition de...
December 11, 2023 13:00 ET | Source: DelveInsight Business Research LLP

HPK1 Inhibitor Market to Witness Upsurge in Growth During the Study Period (2019–2032), Assesses DelveInsight | Key Companies to Look Out - Treadwell, Nimbus, 1ST Biotherapeutics, Zhuhai Yufan Biotechnologies, Pfizer, BeiGene

New York, USA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- HPK1 Inhibitor Market to Witness Upsurge in Growth During the Study Period (2019–2032), Assesses DelveInsight | Key Companies to Look Out -...
November 27, 2023 08:00 ET | Source: Ocuphire Pharma

Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer

FARMINGTON HILLS, Mich., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing...
November 15, 2023 13:00 ET | Source: DelveInsight Business Research LLP

Intratumoral Cancer Therapies Market to Observe Stupendous Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Players - Nanobiotix, Sirnaomics, Apexigen, Replimune, Merck, OncoSec, DNAtrix, Treovir Istari

New York, USA, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Intratumoral Cancer Therapies Market to Observe Stupendous Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Players -...
November 15, 2023 03:00 ET | Source: Myricx Bio

Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors

LONDON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads...
October 25, 2023 08:00 ET | Source: Korro Bio, Inc.

Korro Bio Announces Appointment of Tim Pearson to Board of Directors Upon Closing of the Proposed Merger and Promotion of Todd Chappell to Chief Operating Officer

Tim Pearson, CEO of Carrick Therapeutics and ex-CFO of TESARO, will join as Director contingent on the close of the proposed merger with FrequencyTodd Chappell is elevated to role of Chief Operating...
October 23, 2023 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer

Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer
September 28, 2023 08:00 ET | Source: OncoC4, Inc.

OncoC4 Strengthens Leadership Team with the Appointment of Abid Ansari as Chief Financial Officer

ROCKVILLE, Md., Sept. 28, 2023 (GLOBE NEWSWIRE) -- OncoC4, Inc., a late-stage biopharmaceutical company developing novel medicines for cancer, today announced the appointment of Abid Ansari as Chief...
September 26, 2023 08:30 ET | Source: Ambrx Biopharma Inc.

Ambrx to Host KOL Event Discussing ARX517 Data Presented at ESMO Congress 2023

SAN DIEGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that it will host an in-person key opinion leader (KOL) event during the...